Go to the list of all blogs
Alicia's Avatar
published in Blogs
Apr 23, 2026

Intel (INTC) Surges +48% in 30 Days: AI Deals and Foundry Progress Fuel the Rally

Key Takeaways

  • INTC stock surged +48% over the past 30 days, driven by a historic nine-day winning streak amid AI chip deals and analyst upgrades.
  • Over the past quarter, shares rose +45%, recovering from an early post-earnings drop through foundry progress and product launches.
  • Key catalysts include multi-generation AI agreements, such as with Google, and optimism around server CPUs and AI PCs.
  • Recent HSBC upgrade to Buy with $95 target highlights foundry momentum and cyclical recovery.
  • Upcoming Q1 earnings will be pivotal, with focus on revenue guidance and AI segment growth.

Understanding Intel (INTC): Company Overview and Market Position

Intel Corporation (INTC) stands as a global leader in semiconductor design and manufacturing, producing central processing units (CPUs), graphics processing units (GPUs), and other chips essential for computing, data centers, and artificial intelligence (AI) applications. Its core business spans client computing, data center and AI, foundry services, and mobile communications. Intel competes in the intensely competitive semiconductor industry against players like NVDA and Advanced Micro Devices. From what I see, the recent stock behavior reflects its pivot toward AI accelerators and foundry expansion, bolstered by U.S. government investments and partnerships, aiding recovery from prior manufacturing challenges.

INTC Stock Performance: Breaking Down the Last 30 Days vs. the Quarter

Over the last 30 days, INTC stock climbed from a close of approximately $44 to $65, marking a +48% gain. The movement was trend-driven and volatile, featuring a sharp rally with a nine-day winning streak that propelled shares up 58% during that stretch, followed by minor pullbacks. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

In the past quarter, shares advanced +45% from around $45, exhibiting high volatility—initial declines gave way to sustained upward momentum. The stock ranged from lows near $41 to highs above $68, influenced by earnings reactions and sector tailwinds.

Key Drivers Behind INTC's 30-Day Surge

The 30-day surge in INTC was fueled by accelerating optimism in its AI and foundry segments. Reports of a multi-generation deal with Google for AI chips pushed shares to five-year highs, sparking the historic rally. Analyst upgrades, including HSBC's shift to Buy with a $95 target, cited foundry deals driving a 60% rally. Positive sentiment around CES 2026 launches like Core Ultra Series 3 “Panther Lake” processors and server CPU demand further boosted the stock. Sector strength in semiconductors and anticipation for Q1 earnings, expecting $12.4 billion revenue, sustained the uptrend despite brief pullbacks. One thing that stands out is how these developments align with broader AI trends I'm watching closely.

What Powered INTC's Performance Over the Past Quarter

The quarter began with a sharp 12% drop after Q4 2025 earnings beat estimates ($0.15 adjusted EPS on $13.7 billion revenue) but featured weak Q1 guidance ($11.7-12.7 billion revenue, breakeven EPS), eroding confidence. Recovery followed with AI catalysts: Nvidia investments, U.S. government funding, and AI PC/server optimism propelled shares up 85% year-to-date by mid-April. Industry trends like AI demand and competitive positioning in foundry services had the strongest impact, outweighing macroeconomic pressures. Institutional buying amid upgrades amplified the rebound. In my view, Tickeron’s AI Trend Prediction Engine helps highlight these momentum shifts effectively.

Trending AI Robots: A Tool I Rely On

One resource I turn to regularly is Tickeron’s Trending AI Robots page, which showcases the top-performing AI trading bots from its library of hundreds. These bots analyze and trade thousands of stock tickers across various strategies, timeframes, and performance metrics like win rate, profit factor, and drawdown. The curated selection represents the most relevant and successful ones based on recent market conditions, helping me discover automated tools for pattern recognition, momentum trading, or mean reversion. Whether short-term scalpers or long-term trend followers, they provide data-driven insights that fit into my research process. I often explore the page to find bots suited to my trading style and review their backtest results.

INTC Forecast: What to Watch Moving Forward

Investors should monitor Q1 2026 earnings for updates on revenue ($12.4 billion expected), EPS ($0.01), and foundry progress amid AI CPU demand. Key industry trends include AI accelerator adoption and semiconductor supply chain dynamics. Macro factors like interest rates and geopolitical tensions on chip exports remain relevant. Strategic developments such as 18A process node advancements, partnerships, and competitive responses from peers could sway sentiment. Risks involve guidance misses or delays in turnaround efforts. This is important because these elements will shape the stock's trajectory in the coming months.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations

Related Ticker: INTC

Momentum Indicator for INTC turns negative, indicating new downward trend

INTC saw its Momentum Indicator move below the 0 level on July 02, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 94 similar instances where the indicator turned negative. In of the 94 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for INTC turned negative on July 01, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 41 similar instances when the indicator turned negative. In of the 41 cases the stock turned lower in the days that followed. This puts the odds of success at .

INTC moved below its 50-day moving average on July 07, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for INTC crossed bearishly below the 50-day moving average on July 14, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 19 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where INTC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for INTC entered a downward trend on August 03, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where INTC's RSI Indicator exited the oversold zone, of 25 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 65 cases where INTC's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where INTC advanced for three days, in of 310 cases, the price rose further within the following month. The odds of a continued upward trend are .

INTC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. INTC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 75, placing this stock slightly better than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.811) is normal, around the industry mean (15.439). INTC has a moderately high P/E Ratio (904.167) as compared to the industry average of (229.389). Projected Growth (PEG Ratio) (1.359) is also within normal values, averaging (1.874). Dividend Yield (0.004) settles around the average of (0.016) among similar stocks. P/S Ratio (8.673) is also within normal values, averaging (43.421).

Notable companies

The most notable companies in this group are NVIDIA Corp (NASDAQ:NVDA), Broadcom Inc. (NASDAQ:AVGO), Taiwan Semiconductor Manufacturing Company Ltd (NYSE:TSM), Micron Technology (NASDAQ:MU), Advanced Micro Devices (NASDAQ:AMD), Intel Corp (NASDAQ:INTC), Texas Instruments (NASDAQ:TXN), Marvell Technology (NASDAQ:MRVL), Analog Devices (NASDAQ:ADI), QUALCOMM (NASDAQ:QCOM).

Industry description

The semiconductor industry manufacturers all chip-related products, including research and development. These chips are used in innumerable electronic devices, including computers, cell phones, smartphones, and GPSs. Intel Corporation, NVIDIA Corp., and Broadcomm are some of the prominent players in this industry. Semiconductor companies usually tend to do well during periods of healthy economic growth, thereby inducing further research and development in the industry – which in turn augurs well for productivity and growth in the economy. In the near future, demand for semiconductor products (and possibly innovation within the segment) should only expand further, with the proliferation of 5G, autonomous vehicles, IoT, and various AI-driven electronics set to herald a new, advanced chapter in the technology-driven world as we know it. With burgeoning prospects comes great competition. In 2015, SIA estimated that U.S. semiconductor industry ranks as the second most competitive U.S. industry out of 2882 U.S. industries designated manufacturers by the U.S. Census Bureau.

Market Cap

The average market capitalization across the Semiconductors Industry is 181.32B. The market cap for tickers in the group ranges from 13.43K to 5.13T. NVDA holds the highest valuation in this group at 5.13T. The lowest valued company is CYBL at 13.43K.

High and low price notable news

The average weekly price growth across all stocks in the Semiconductors Industry was 12%. For the same Industry, the average monthly price growth was -6%, and the average quarterly price growth was 53%. ALAB experienced the highest price growth at 39%, while NXPI experienced the biggest fall at -8%.

Volume

The average weekly volume growth across all stocks in the Semiconductors Industry was -17%. For the same stocks of the Industry, the average monthly volume growth was -31% and the average quarterly volume growth was -64%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 60
P/E Growth Rating: 52
Price Growth Rating: 52
SMR Rating: 76
Profit Risk Rating: 74
Seasonality Score: -27 (-100 ... +100)
View a ticker or compare two or three
INTC
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a manufacturer of computer components and related products

Industry Semiconductors

Profile
Details
Industry
Semiconductors
Address
2200 Mission College Boulevard
Phone
+1 408 765-8080
Employees
85100
Web
https://www.intel.com
Interact to see
Advertisement
Novartis (NVS) reports Q4/FY 2025 earnings on February 4, 2026, with consensus calling for ~$1.99 EPS on ~$13.7 billion in revenue. Sanofi (SNY) delivered strong FY 2025 results on January 29, reporting €43.6 billion in sales (+9.9% CER) and 15% business EPS growth.
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
MUFG is expected to report Q3 FY2026 EPS of about $0.30, broadly in line with its recent pattern of earnings beats.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
CME Group (CME): Q4 2025 earnings due February 4, 2026; consensus expects adjusted EPS $2.75 and revenue ~$1.6B. S&P Global (SPGI): Q4 2025 earnings due February 10, 2026; Q3 posted EPS $4.73 and 9% revenue growth, driven by Ratings, Indices, and Market Intelligence.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.
Intel (INTC) Surges +48% in 30 Days: AI Deals and Foundry Progress Fuel the Rally